Synthetic Cationic Autoantigen Mimics Glatiramer Acetate Persistence at the Site of Injection and Is Efficacious Against Experimental Autoimmune Encephalomyelitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic Cationic Autoantigen Mimics Glatiramer Acetate Persistence at the Site of Injection and Is Efficacious Against Experimental Autoimmune Encephalomyelitis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-18
DOI
10.3389/fimmu.2020.603029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Linking autoantigen properties to mechanisms of immunity
- (2020) J. Daniel Griffin et al. ADVANCED DRUG DELIVERY REVIEWS
- Tocopherol Emulsions as Functional Autoantigen Delivery Vehicles Evoke Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis
- (2019) J. Daniel Griffin et al. MOLECULAR PHARMACEUTICS
- Antigen-specific immune decoys intercept and exhaust autoimmunity to prevent disease
- (2019) J. Daniel Griffin et al. BIOMATERIALS
- Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitis
- (2018) Brittany L. Hartwell et al. JOURNAL OF AUTOIMMUNITY
- Improved Fluorescence Methods for High-Throughput Protein Formulation Screening
- (2018) Yangjie Wei et al. SLAS Technology
- Glatiramer acetate persists at the injection site and draining lymph nodes via electrostatically-induced aggregation
- (2018) Jimmy Y. Song et al. JOURNAL OF CONTROLLED RELEASE
- Co-delivery of autoantigen and dexamethasone in incomplete Freund's adjuvant ameliorates experimental autoimmune encephalomyelitis
- (2017) Laura Northrup et al. JOURNAL OF CONTROLLED RELEASE
- Immunomodulation neuroprotection and remyelination – The fundamental therapeutic effects of glatiramer acetate: A critical review
- (2014) Rina Aharoni JOURNAL OF AUTOIMMUNITY
- Synthetic Peptide Dendrimers Block the Development and Expression of Experimental Allergic Encephalomyelitis
- (2014) K. W. Wegmann et al. JOURNAL OF IMMUNOLOGY
- Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis
- (2014) Keith W. Wegmann et al. JOURNAL OF NEUROIMMUNOLOGY
- Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
- (2014) Dean M. Wingerchuk et al. MAYO CLINIC PROCEEDINGS
- Glatiramer acetate ameliorates experimental autoimmune neuritis
- (2013) Cun-Jin Zhang et al. IMMUNOLOGY AND CELL BIOLOGY
- Fluorescence Imaging of the Lymph Node Uptake of Proteins in Mice after Subcutaneous Injection: Molecular Weight Dependence
- (2012) Fang Wu et al. PHARMACEUTICAL RESEARCH
- Glatiramer Acetate in the Treatment of Multiple Sclerosis
- (2011) Patrice H. Lalive et al. CNS DRUGS
- Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate
- (2011) Rina Aharoni et al. JOURNAL OF AUTOIMMUNITY
- Recent insights into the mechanism of action of glatiramer acetate
- (2011) Mrinalini Kala et al. JOURNAL OF NEUROIMMUNOLOGY
- A New Drug Candidate (GEMSP) for Multiple Sclerosis
- (2009) Arturo Mangas et al. CURRENT MEDICINAL CHEMISTRY
- The glatiramoid class of immunomodulator drugs
- (2009) Haim Varkony et al. EXPERT OPINION ON PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now